We synthesized several novel compounds to evaluate the different effects of non-iodinated and mono- or diiodinated
benzoic acid on the cellular and nuclear uptake of the SV 40
T antigen nuclear localization sequence (NLS) in human LN18 and U373
glioma cells. The skeletal structure of all the conjugates contained the
fluorescein isothiocyanate (
FITC)-labeled NLS of the SV 40T
antigen, to which either
benzoic acid, mono- or diiodobenzoic
acid was coupled. As shown by confocal
laser scanning microscopy (CLSM) and fluorescence-activated cell sorting (FACS), the basic
FITC-labeled NLS alone was taken up by the nuclei of only a few
glioma cells which remained intact. The coupling of non-iodinated
benzoic acid (BA) did not result in a markedly larger number of nuclearly stained cells. A very marked increase in cells with nuclear staining was found with the conjugate containing monoiodobenzoic
acid (MIBA). This was also associated with a high cell death rate. Similar results were obtained with the conjugate containing diiodobenzoic
acid (
DIBA). However, coincubation with free mono- or diiodobenzoic
acid and the basic
FITC-labeled NLS did not result in a marked change in the number of strongly stained cells or cell viability compared to the results of incubation with the
FITC-labeled NLS alone. Surprisingly,
FITC-labeled MIBA- and
DIBA-conjugates containing a scrambled SV 40
T antigen NLS were also taken up by the cell nuclei of LN18 and U373
glioma cells and led to cell death. Such mono- or diiodobenzoic
acid conjugates may therefore have potential in the development of new non-radioactive drugs against
malignant glioma cells.